Managing overactive bladder with mirabegron: Practical insights

Description

In this Product Explainer, Urologist Dr Jeff Thavaseelan discusses the role of mirabegron in overactive bladder management, including its mechanism of action, safety profile, treatment positioning, and practical considerations for patient selection and referral (6 mins).

Astellas Pharma Australia Pty Ltd Suite 2.01, 2 Banfield Rd, Macquarie Park NSW 2113.
MAT-AU-BET-2026-00053 – August 2026

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel – A/Prof Samantha Hocking & Dr Terri-Lynne South, facilitated by A/Prof Ralph Audehm

Expert panel – A/Prof Samantha Hocking & Dr Terri-Lynne South, facilitated by A/Prof Ralph Audehm

GLP 1s & Sarcopenia: Fact vs Hype

Dr Deb Mills

Dr Deb Mills

The New Dengue Vaccine – What You Need to Know

Dr Robert Hungerford

Dr Robert Hungerford

Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk

A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Management of Photoageing

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Jeff Thavaseelan

expert

Dr Jeff Thavaseelan

Urologist, Perth Urology Clinic

Date published: 1 September 2026